9-100292976-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_014425.5(INVS):c.2719C>T(p.Arg907*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R907R) has been classified as Benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_014425.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- nephronophthisis 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- Senior-Loken syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| INVS | NM_014425.5 | c.2719C>T | p.Arg907* | stop_gained | Exon 14 of 17 | ENST00000262457.7 | NP_055240.2 | |
| INVS | NM_001318381.2 | c.2431C>T | p.Arg811* | stop_gained | Exon 15 of 18 | NP_001305310.1 | ||
| INVS | NM_001318382.2 | c.1741C>T | p.Arg581* | stop_gained | Exon 14 of 17 | NP_001305311.1 | ||
| INVS | NR_134606.2 | n.2868C>T | non_coding_transcript_exon_variant | Exon 14 of 17 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152116Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000159 AC: 4AN: 251354 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461308Hom.: 0 Cov.: 35 AF XY: 0.0000165 AC XY: 12AN XY: 726838 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74450 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Infantile nephronophthisis Pathogenic:5
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with infantile nephronophthisis 2 (MIM#602088). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (4 heterozygotes, 0 homozygotes). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. These variants have been reported many times as pathogenic (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported in multiple homozygous and compound heterozygous families with end stage renal disease, renal cysts and infantile renal disease (ClinVar, PMID: 19177160, PMID: 12872123). (SP) 1102 - Strong phenotype match for this individual. (SP) 1206 - This variant has been shown to be paternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
- -
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.002%). Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000011961 /PMID: 12872123). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
A known stop-gain variant c.2719C>T in exon 14 of INVS (Tory et al., 2009; Clinvar Accession: VCV000011961.10) was identified in a heterozygous state in the proband and her husband. This variant is present in 26 individuals in heterozygous state (allele frequency: 0.00001611) in the gnomAD (v4.1.0) population database. This variant is absent in our in-house database of 3709 exomes. The variant c.2719C>T is predicted to introduce premature termination codon, which may either trigger nonsense-mediated mRNA decay or result in a truncated protein product. -
- -
INVS-related disorder Pathogenic:1
The INVS c.2719C>T variant is predicted to result in premature protein termination (p.Arg907*). This variant was reported in homozygous and compound heterozygous states in multiple individuals with Nephronophthisis 2 (Otto et al. 2003. PubMed ID: 12872123; O'Toole et al. 2006. PubMed ID: 16522655; Chaki et al. 2011. PubMed ID: 21866095; Tory et al. 2009. PubMed ID: 19177160). This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD. Loss-of-function variants in INVS, like this nonsense change, are expected to be pathogenic. This variant is interpreted as pathogenic. -
Nephronophthisis Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg907*) in the INVS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in INVS are known to be pathogenic (PMID: 12872123). This variant is present in population databases (rs267607185, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with nephronophthisis (PMID: 12872123, 16522655, 21866095). ClinVar contains an entry for this variant (Variation ID: 11961). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at